Nurix Therapeutics Inc. (NRIX)

14.16

-1.29 (-8.35%)

At close: Mar 03, 2025, 3:59 PM

14.47

2.15%

After-hours: Mar 03, 2025, 04:03 PM EST

Nurix Therapeutics Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-193.57M	-143.95M	-180.36M	-117.19M	-43.24M	-21.7M	-9.43M
Depreciation & Amortization	-1.97M	13.65M	10.81M	6.08M	2.18M	2.35M	2.99M
Stock-Based Compensation	33.93M	33.67M	28.13M	15.8M	4.3M	510K	431K
Other Working Capital	-23.61M	18.51M	-25.11M	6.75M	35.17M	19.24M	-24.79M
Other Non-Cash Items	-10.97M	-4.87M	636K	1.83M	273K	-109K	-6K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	-354K
Change in Working Capital	n/a	20.12M	-19.02M	9.11M	36.41M	19.55M	-25.31M
Operating Cash Flow	-172.58M	-81.36M	-159.81M	-84.36M	-80K	601K	-31.68M
Capital Expenditures	-9.27M	-8.4M	-12.24M	-5.66M	-4.55M	-1.65M	-1.59M
Acquisitions	n/a	n/a	-39.44M	102.59M	249.85M	-10.15M	6K
Purchase of Investments	-707.95M	-246.33M	-239.37M	-348.5M	-275.22M	-9.35M	-12.92M
Sales Maturities Of Investments	459.51M	323.04M	278.81M	245.91M	25.37M	19.5M	54.5M
Other Investing Acitivies	n/a	n/a	39.44M	-102.59M	-249.85M	10.15M	6K
Investing Cash Flow	-257.71M	68.3M	27.2M	-108.25M	-254.4M	8.5M	39.99M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-16K	-2K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	7.17M	3.22M	97.79M	3.73M	120.88M	126K	529K
Financial Cash Flow	485.67M	3.22M	117.19M	153.88M	339.02M	126K	529K
Net Cash Flow	55.37M	-9.85M	-15.42M	-38.73M	84.54M	9.22M	8.85M
Free Cash Flow	-181.86M	-89.77M	-172.05M	-90.03M	-4.63M	-1.05M	-33.27M